BP1 Protein and Breast Cancer Cell Survival
Author Information
Author(s): Holly S Stevenson, Sidney W Fu, Joseph J Pinzone, Jinguen Rheey, Samuel J Simmens, Patricia E Berg
Primary Institution: Center for Cancer Research, National Cancer Institute, National Institutes of Health
Hypothesis
Does elevated BP1 expression in breast cancer cells correlate with increased cell survival?
Conclusion
Increased BP1 expression in breast cancer cells inhibits apoptosis and may contribute to resistance against therapies.
Supporting Evidence
- BP1 is expressed in 81% of invasive ductal breast carcinomas.
- Increased BP1 expression correlates with tumor progression.
- Stable overexpression of BP1 inhibits apoptosis in MCF7 cells treated with TNFα.
- BP1 directly activates the bcl-2 gene, an antiapoptotic factor.
- MCF7 cells with BP1 overexpression show increased bcl-2 mRNA and protein levels.
Takeaway
BP1 helps breast cancer cells live longer by stopping them from dying when they should, which might make treatments less effective.
Methodology
MCF7 cells were treated with TNFα and analyzed for cell viability and apoptosis using MTT and Annexin V assays, along with Western blot and PCR techniques.
Potential Biases
Potential bias due to the use of a single cell line and specific experimental conditions.
Limitations
The study primarily focuses on one cell line and may not represent all breast cancer types.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website